TIFFANY HAYES: Open Payments
NPI 1831356658 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 82 payments from 10 companies in 2025. Trend: 2023 $1,167 · 2024 $1,412 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $328 |
| ABBVIE INC. | 24 | $294 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $253 |
| AstraZeneca Pharmaceuticals LP | 9 | $159 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, Wegovy, Ozempic, AIRSUPRA, REXULTI, FARXIGA, Rybelsus.
Industry payments across TN — which companies pay providers there.
